UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000025843
Receipt No. R000029718
Official scientific title of the study Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis
Date of disclosure of the study information 2017/02/01
Last modified on 2019/01/10 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Inositol treatment for polycystic ovary syndrome (PCOS): Systematic review and meta-analysis
Title of the study (Brief title) Inositol treatment for PCOS
Region
Japan

Condition
Condition polycystic ovary syndrome
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of inositol on outcome in PCOS.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Parameters of glucose metabolism
Ovarian function
Key secondary outcomes Serum sex hormone

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria All randomized controlled trial comparing inositol with placebo intake in PCOS are included in this study.
Key exclusion criteria We exclude studies that is not report our primary and secondary outcomes.
We also exclude studies that did not set appropriate control group, is review article and is not clinical study.
Target sample size 100

Research contact person
Name of lead principal investigator Makoto Nakano
Organization Yokohama University of Pharmacy
Division name General Health Medical Center
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Email m.nakano@hamayaku.ac.jp

Public contact
Name of contact person Kohsuke Hayamizu
Organization Yokohama University of Pharmacy
Division name Laboratory of Food Chemistry
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Homepage URL
Email k.hayamizu@hamayaku.ac.jp

Sponsor
Institute Yokohama University of Pharmacy
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 13 Day
Anticipated trial start date
2017 Year 01 Month 26 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information Preparing to submit a paper

Management information
Registered date
2017 Year 01 Month 25 Day
Last modified on
2019 Year 01 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029718